LICITRA, LISA FRANCESCA LINDA
LICITRA, LISA FRANCESCA LINDA
Dipartimento di Oncologia ed Emato-Oncologia
INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
2026 D. Rischin, A. R Hansen, E.E. W Cohen, M. Tahara, K. J Harrington, R. I Haddad, L. Licitra, H. Mehanna, R. L Ferris, P. Koralewski
Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials
2025 C. Gurizzan, M. Cinquini, L. Legramandi, C. Resteghini, M. Siano, C. Bergamini, L. Lorini, D. Smussi, A. Paderno, L. Licitra, P. Bossi
The role of volumetry in sinonasal cancer response assessment to induction chemotherapy, results from two phase II non-randomized controlled prospective multicentric trials: SINTART-1 and SINTART-2
2025 P. Rondi, D. Mattavelli, V. Rampinelli, A. Schreiber, E. Orlandi, B. Vischioni, N.A. Iacovelli, G. Calareso, C. Bergamini, S. Alfieri, P. Castelnuovo, P. Battaglia, M. Turri-Zanoni, P. Nicolai, M. Ferrari, L. Licitra, P. Bossi, D. Farina, M. Ravanelli, C. Resteghini
Ferroptosis-Related Gene Signatures: Prognostic Role in HPV-Positive Oropharyngeal Squamous Cell Carcinoma
2025 D. Lenoci, M.S. Serafini, M. Lucchetta, S. Cavalieri, R.H. Brakenhoff, F. Hoebers, K. Scheckenbach, T. Poli, L. Licitra, L. De Cecco
Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma
2025 A. Corti, D. Lenoci, V.D.A. Corino, D. Mattavelli, M. Ravanelli, T. Poli, S. Cavalieri, L. Licitra, L. De Cecco, L. Mainardi
Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma
2025 J.-. Machiels, Y. Tao, L. Licitra, B. Burtness, M. Tahara, D. Rischin, G.V. Alves, I.P.F. Lima, B.G.M. Hughes, Y. Pointreau, S. Aksoy, S. Laban, R. Greil, M. Burian, M. Hetnal, J.-. Delord, R. Mesia, M. Taberna, J. Waldron, C. Simon, V. Gregoire, K. Harrington, C.M. Black, J.M. Norquist, A. Wang, B. Gumuscu, B. Bidadiand, L.L. Siu
Clonality, Virulence Genes, and Antimicrobial Resistance of Dairy Ruminants in Mastitic Milk-Associated Staphylococcus aureus in Sicily
2025 N. Russo, N. Alberto Fazio, F. Licitra, J. Gajewska, A. Stamilla, R. Salonia, W. Chajęcka-Wierzchowska, C.L. Randazzo, C. Caggia, F. Antoci, G. Cascone
Indirect comparison ofTPF and GP induction chemotherapy regimens in nasopharyngeal carcinoma: a data-driven reassessment before the transition to induction chemoimmunotherapy
2025 S. Cavalieri, A. Ottini, B.L. Stocchetti, L. Licitra
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian Centers
2025 F. Caspani, S. Cavalieri, E. Orlandi, C. Bergamini, C. Resteghini, E. Colombo, A. Ottini, I. Nuzzolese, S. Alfieri, A. Mirabile, A. Cassano, P. Bossi, T. Ibrahim, M.C. Cau, M. Ghiani, F. Bertolini, R. Ingargiola, G. Fontana, L. Licitra, L.D. Locati
The Role of Cetuximab in Non-Melanoma Skin Cancer: A Review of Clinical Evidence and Emerging Strategies
2025 I. Nuzzolese, S. Cavalieri, L.F. Licitra, S. Alfieri
Personalized treatment in HPV+ oropharynx cancer using genomic adjusted radiation dose
2025 E. Ho, L. De Cecco, S.A. Eschrich, S. Cavalieri, G. Sedor, F. Hoebers, R.H. Brakenhoff, K. Scheckenbach, T. Poli, K. Yang, J.A. Scarborough, S. Nellore, S. Campbell, N. Woody, T. Chan, J. Miller, N. Silver, S. Koyfman, J. Bates, J.J. Caudell, M.W. Kattan, L. Licitra, J.F. Torres-Roca, J.G. Scott
Transcriptomic based prognostic model versus TNM 9th edition in HPV-positive oropharyngeal cancer
2025 S. Cavalieri, R.H. Brakenhoff, C.R. Leemans, F. Hoebers, K. Scheckenbach, T.K. Hoffmann, D. Mattavelli, T. Poli, E. Orlandi, L. Licitra, L. De Cecco
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial
2025 P. Bossi, A. Alberti, C. Bergamini, C. Resteghini, L.D. Locati, S. Alfieri, S. Cavalieri, E. Colombo, C. Gurizzan, L. Lorini, V. Tovazzi, M. Zamparini, M. Ravanelli, P.A. Ascierto, V. Rampinelli, A. Grammatica, R. Patuzzo, A. Maurichi, L.F. Licitra
Gender Diversity in the Middle Management Matters: Examining Gender Metrics for Organizational and Sustainable Success
2025 A.D. Chiaramonte, C. Marazzi, D. Terruzzin, L. Anemoni, A. Mereghetti, E. Orlandi, L. Licitra
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
2025 R. Galot, C. Le Tourneau, L. Licitra, J. Guigay, A. Kong, I. Tinhofer, C. Even, A. Daste, S. Henry, C. Borel, C. Abdeddaim, E. Seront, J.B. Prevost, A. Rutten, E. Saada-Bouzid, F. Rolland, P. Bonomo, M. Rasschaert, L. Dirix, C. Olungu, K. Tsechilidou, A.S. Govaerts, C. Fortpied, A. Joaquim, J.P. Machiels
Treatment decision-making factors and sequencing in recurrent and/or metastatic squamous cell carcinoma of the head and neck
2025 P. Szturz, T. Fuereder, Y. Guo, L. Licitra, R. Mesia, P. Ivanyi, A. Falco, M. Tahara, M.-. Solbes, F. Venturini, P. Bossi
Sinonasal Sarcomas Management: An International Consensus Statement
2025 A. Vinciguerra, F. Caspani, M. Valentini, A.M. Camarda, S. Provenzano, E.W. Wang, C. Meco, M. Ferrari, P. Surda, S. Harrabi, F.A.B. Campos, J.M. Broto, B.A. Guadagnolo, P. Navarria, A. Hosni, N. Hindi, A. Italiano, D.M. Trifiletti, B. Kasper, B. Verillaud, A. Schreiber, P. Castelnuovo, P. Nicolai, I. Dallan, M. Chacon, S.Y. Su, J. Thariat, C. Valverde, M. Lechner, J.Y. Blay, M.R. Fiore, J.A. Eloy, M. Brahmi, J.N. Palmer, V.C. Oliden, D. Greto, I. Lugowska, A.P.D. Tos, T. Van Zele, A.J. Psaltis, P.G. Casali, A. Dufresne, C. Sangalli, C. Georgalas, E. Orlandi, P.-. Wormald, P. Herman, R. Carrau, E.Y. Hanna, L. Licitra, M. Turri-Zanoni, P. Battaglia
Impact of head and neck cancer on the income of Italian employees
2025 A. Macciotta, A. Trama, A. Bernasconi, L. Licitra, R. Leombruni, M. Malisan, F. Ricceri, N. Zengarini, E. Farina
Development, Validation, and Valuation of a Head and Neck Cancer-Specific Health Utility Instrument (HNC-8D): A Head and Neck Cancer International Group Collaborative Study
2025 J.R. De Almeida, J. Su, A. Alshenaiber, H. Noroozi, M. Buttner, D.P. Goldstein, A. Hansen, L.P. Kowalski, L. Licitra, H. Mehanna, C.W. Noel, A. Parmar, S. Porceddu, J. Ringash, S. Rogers, M.A. Dos Santos, C. Simon, M.-. Truong, W. Xu
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy era
2025 A. Alberti, C. Gurizzan, C. Resteghini, A. Trama, A. Bernasconi, S. Grisanti, M. Zamparini, I. Mohamad, I. Linares Galiana, E. Ozyar, P. Franco, S. Vecchio, P. Bonomo, B. Cirauqui, M. El-Sherify, S. Ursino, A. Argiris, J. Pan, C. Wittekindt, E. D'Angelo, L. Costa, M. Buglione, J.M. Johnson, M. Airoldi, R. Mesia, L. Licitra, E. Orlandi, P. Bossi